APP and Alzheimer disease: The Aβ (1–42) peptide derived from APP through the cleavage of γ-secretases and β-secretases, is the predominant aggregated and neurotoxic form of Aβ found in the brain of AD patients due to its two additional hydrophobic amino acids (Butterfield et al., 2013; Xiao et al., 2015).